Early predicting of preeclampsia in pregnant women after assisted reproductive technologies

Aim: to identify new prognostic criteria of potential preeclampsia (PE) in pregnant women after assisted reproductive technologies (ART) for timely PE prophylaxis.Materials and methods. A prospective study of 85 patients who entered the program of ART was conducted. All patients were examined for po...

Full description

Bibliographic Details
Main Authors: E. G. Pitskhelauri, A. N. Strizhakov, N. A. Bogacheva, T. E. Kuzmina, I. A. Fedyunina
Format: Article
Language:Russian
Published: IRBIS LLC 2020-01-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/599
_version_ 1797884121841664000
author E. G. Pitskhelauri
A. N. Strizhakov
N. A. Bogacheva
T. E. Kuzmina
I. A. Fedyunina
author_facet E. G. Pitskhelauri
A. N. Strizhakov
N. A. Bogacheva
T. E. Kuzmina
I. A. Fedyunina
author_sort E. G. Pitskhelauri
collection DOAJ
description Aim: to identify new prognostic criteria of potential preeclampsia (PE) in pregnant women after assisted reproductive technologies (ART) for timely PE prophylaxis.Materials and methods. A prospective study of 85 patients who entered the program of ART was conducted. All patients were examined for possible hemostatic abnormalities (genetic thrombophilia and chronic hypercoagulation) and also for granulocytemacrophage colony-stimulating factor (GM-CSF) in the serum during the most critical periods (4–6, 12–14, 22–24 и and 30–32 weeks) of the fetoplacental complex formation.Results. The lowest level of GM-CSF was observed in patients with hemostatic disorders. Thus, in pregnant women who later developed PE, there was a decrease in GM-CSF level below the physiological: in those diagnosed with genetic thrombophilia – by 79.4 %, and those with hypercoagulation – by 63.6 %.Conclusion. The determination of serum GM-CSF and identification of hemostatic abnormalities in pregnant women after ART has a prognostic importance for potential PE. This result is significant for the understanding of the pathogenesis of PE and also has a practical value: it allows the doctor to attribute the patient to a high risk group from the first trimester of her pregnancy and start preventive therapy rather early.
first_indexed 2024-04-10T04:01:27Z
format Article
id doaj.art-40a52905cc314973b907f540f375a485
institution Directory Open Access Journal
issn 2313-7347
2500-3194
language Russian
last_indexed 2024-04-10T04:01:27Z
publishDate 2020-01-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj.art-40a52905cc314973b907f540f375a4852023-03-13T07:09:50ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942020-01-0113430531210.17749/2313-7347.2019.13.4.305-312522Early predicting of preeclampsia in pregnant women after assisted reproductive technologiesE. G. Pitskhelauri0A. N. Strizhakov1N. A. Bogacheva2T. E. Kuzmina3I. A. Fedyunina4Sechenov UniversitySechenov UniversitySechenov UniversitySechenov UniversitySechenov UniversityAim: to identify new prognostic criteria of potential preeclampsia (PE) in pregnant women after assisted reproductive technologies (ART) for timely PE prophylaxis.Materials and methods. A prospective study of 85 patients who entered the program of ART was conducted. All patients were examined for possible hemostatic abnormalities (genetic thrombophilia and chronic hypercoagulation) and also for granulocytemacrophage colony-stimulating factor (GM-CSF) in the serum during the most critical periods (4–6, 12–14, 22–24 и and 30–32 weeks) of the fetoplacental complex formation.Results. The lowest level of GM-CSF was observed in patients with hemostatic disorders. Thus, in pregnant women who later developed PE, there was a decrease in GM-CSF level below the physiological: in those diagnosed with genetic thrombophilia – by 79.4 %, and those with hypercoagulation – by 63.6 %.Conclusion. The determination of serum GM-CSF and identification of hemostatic abnormalities in pregnant women after ART has a prognostic importance for potential PE. This result is significant for the understanding of the pathogenesis of PE and also has a practical value: it allows the doctor to attribute the patient to a high risk group from the first trimester of her pregnancy and start preventive therapy rather early.https://www.gynecology.su/jour/article/view/599pregnancygranulocyte-macrophage colony-stimulating factorgenetic thrombophiliachronic hypercoagulationpreeclampsia
spellingShingle E. G. Pitskhelauri
A. N. Strizhakov
N. A. Bogacheva
T. E. Kuzmina
I. A. Fedyunina
Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
Акушерство, гинекология и репродукция
pregnancy
granulocyte-macrophage colony-stimulating factor
genetic thrombophilia
chronic hypercoagulation
preeclampsia
title Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
title_full Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
title_fullStr Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
title_full_unstemmed Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
title_short Early predicting of preeclampsia in pregnant women after assisted reproductive technologies
title_sort early predicting of preeclampsia in pregnant women after assisted reproductive technologies
topic pregnancy
granulocyte-macrophage colony-stimulating factor
genetic thrombophilia
chronic hypercoagulation
preeclampsia
url https://www.gynecology.su/jour/article/view/599
work_keys_str_mv AT egpitskhelauri earlypredictingofpreeclampsiainpregnantwomenafterassistedreproductivetechnologies
AT anstrizhakov earlypredictingofpreeclampsiainpregnantwomenafterassistedreproductivetechnologies
AT nabogacheva earlypredictingofpreeclampsiainpregnantwomenafterassistedreproductivetechnologies
AT tekuzmina earlypredictingofpreeclampsiainpregnantwomenafterassistedreproductivetechnologies
AT iafedyunina earlypredictingofpreeclampsiainpregnantwomenafterassistedreproductivetechnologies